Join partners Takeshi Nakao (Tokyo) and Vinita Kailasanath (Silicon Valley) for the latest episode of the Freshfields MedTech podcast. With a focus on Japan and the US, they discuss trends and innovations in MedTech, and potential risk and regulation that companies with MedTech products and services face.
Introduction (English translation): Hello everyone. My name is Takeshi, Managing Partner of Freshfields Tokyo Office. In today's podcast, we will discuss MedTech. MedTech is the word combining “medical” and “technology”, referring to using IOT and other technologies in healthcare. I will ask the speaker about this area, starting with the definition, which I am sure many of you have heard recently. Technology developments have led to many innovations in the field of healthcare, making it one of the growth areas and an area of high interest. Today I would like to bring you together with an expert in this field from the United States, Vinita Kailasanath. Vinita is the head of Freshfields' MedTech practice and has extensive experience in the field, particularly where both life sciences and technology are concerned. She has been involved in transactions that are strategically very important to our clients in the MedTech and digital health sectors. She provides advice in licensing transactions, research and development, and those kinds of areas. In fact, before becoming a lawyer, Vinita was doing research in the field of neuroendocrinology at the graduate level, which is a word I looked up in the dictionary. She also has experience providing marketing and sales support to pharmaceutical and biotech companies.
Outro (English translation): This time, we started with a high-level conversation with the theme of MedTech, explaining recent trends in regulations. Vinita is an expert in the field of MedTech, and we would like to send you another podcast when we hear about new developments as new trends emerge, etc.. Thank you for listening.
Future trends in MedTech
Essential Antitrust #20: Innovation-driven deals: plan for success (part 2)
Essential Antitrust #19: Innovation-driven deals: plan for success (part 1)
UAE employee monitoring and compliance #3: strategies and best practice to combat cyberattacks, mitigate and manage risks
Essential Antitrust #18: US review of merger guidelines: what could it mean for M&A?
Investing in tech: trends to watch in the year ahead
Managing risk in Asia #5: Investment strategy risk in a dynamic region
UK financial services enforcement in 2021 – Themes and a landmark
Essential Antitrust #17: Antitrust in 2022: 10 key themes - is your business ready for rapid change?
Tax matters: German election – what does the new coalition mean to business?
Investing in tech: regulation to disrupt tech deal-making?
The Big Conversation podcast: Future risks
Spotlight on Africa - The Evolution of our Africa Practice
Buyer beware: avoiding privacy and cyber hazards in M&A
The Big Conversation podcast: the transition to net zero
Fintech in focus: why governance matters
Essential Foreign Investment #3: Developments in the US and China
Tax matters: Digital taxes and trade wars – will the OECD/G20 agreement bring tax peace?
Essential Antitrust Asia #5: Update with Gilbert + Tobin on proposals to reform Australia’s merger regime
What does BT 21, the EU’s ‘business taxation for the 21st century’ package, mean for US business?
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money